UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial

Clinical cancer research, 2022-11, Vol.28 (22), p.4885-4892

2022

Volltextzugriff (PDF)

Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses

Vaccine, 2021-03, Vol.39 (11), p.1583-1592

2021

Volltextzugriff (PDF)

Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors

Journal of Immunology, 2007-04, Vol.178 (7), p.4169-4176

2007

Volltextzugriff (PDF)

Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells

The Journal of immunology (1950), 2014-05, Vol.192 (9), p.4174-4183

2014

Volltextzugriff (PDF)

Recombinant antibodies for delivery of antigen: a single loop between β-strands in the constant region can accommodate long, complex and tandem T cell epitopes

International immunology, 2008-03, Vol.20 (3), p.295-306

2008

Volltextzugriff (PDF)

Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno‐free CTS Immune Cell Serum Replacement

Clinical & translational immunology, 2015-01, Vol.4 (1), p.e31-n/a

2015

Volltextzugriff (PDF)

Novel APC-like properties of human NK cells directly regulate T cell activation

The Journal of clinical investigation, 2004-12, Vol.114 (11), p.1612-1623

2004

Volltextzugriff (PDF)

A mouse Cκ‐specific T cell clone indicates that DC‐SIGN is an efficient target for antibody‐mediated delivery of T cell epitopes for MHC class II presentation

International immunology, 2002-12, Vol.14 (12), p.1423-1430

2002

Volltextzugriff (PDF)

Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes

Journal of leukocyte biology, 2005-03, Vol.77 (3), p.303-310

2005

Volltextzugriff (PDF)

Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target

The Journal of immunology (1950), 2003-07, Vol.171 (1), p.32-36

2003

Volltextzugriff (PDF)

Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates

Vaccine, 2007-06, Vol.25 (24), p.4723-4734

2007

Volltextzugriff (PDF)

Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level

Molecular immunology, 2008-04, Vol.45 (8), p.2380-2390

2008

Volltextzugriff (PDF)

Antibody‐mediated delivery of antigen to chemokine receptors on antigen‐presenting cells results in enhanced CD4+ T cell responses

European journal of immunology, 2003-11, Vol.33 (11), p.3101-3108

2003

Volltextzugriff (PDF)

Novel APC-like properties of human NK cells directly regulate T cell activation

The Journal of clinical investigation, 2004-12, Vol.114 (11), p.1612-1623

2004

Volltextzugriff (PDF)

Xeno-free serum replacement for ex vivo culture and expansion of T cells

Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.P37-P37, Article P37

2014

Volltextzugriff (PDF)

Novel APC-like properties of human NK cells directly regulate T cell activation

The Journal of clinical investigation, 2015-04, Vol.125 (4), p.1763-1763

2015

Volltextzugriff (PDF)

Rapid isolation of pure, functional and bead-free T cells directly from whole blood using Dynabeads® FlowCompTM technology (42.11)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.42-42.11

2009

Volltextzugriff (PDF)

Retraction. Novel APC-like properties of human NK cells directly regulate T cell activation

The Journal of clinical investigation, 2015-04, Vol.125 (4), p.1763-1763

2015

Volltextzugriff (PDF)

Recombinant antibodies for delivery of antigen: a single loop between -strands in the constant region can accommodate long, complex and tandem T cell epitopes

International immunology, 2008-03, Vol.20 (3), p.295-306

2008

Volltextzugriff (PDF)

Abstract A003: High-throughput TCR sequencing demonstrates induction of long-lasting HPV16-specific T cell responses in VB10.16 vaccinated advanced cervical cancer patients

Cancer immunology research, 2023-12, Vol.11 (12_Supplement), p.A003-A003

2023

Volltextzugriff (PDF)

Abstract CT274: Individualized APC targeting VB10.NEO cancer vaccines induce broad neoepitope-specific CD8 T cell responses in patients with advanced or metastatic solid tumors: interim results from a phase 1/2a trial

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT274-CT274

2023

Volltextzugriff (PDF)

Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen‐specific CD4+8+ thymocytes

European journal of immunology, 2005-11, Vol.35 (11), p.3142-3152

2005

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Immunology
(13)
Humans
(9)
Animals
(6)
Antigen Presentation
(6)
Cd4-Positive T-Lymphocytes - Immunology
(6)
Mice
(6)
Lymphocytes
(5)
Antibodies, Monoclonal - Immunology
(4)
Antigen-Presenting Cells - Immunology
(4)
Antigens
(4)
Cell Line
(4)
Medicine, Research & Experimental
(4)
Research & Experimental Medicine
(4)
Antibodies
(3)
Cell Proliferation
(3)
Immunity, Innate
(3)
Immunoglobulin Kappa-Chains - Immunology
(3)
Ligands
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial

Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses

Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors

Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells

Recombinant antibodies for delivery of antigen: a single loop between β-strands in the constant region can accommodate long, complex and tandem T cell epitopes

Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno‐free CTS Immune Cell Serum Replacement

Novel APC-like properties of human NK cells directly regulate T cell activation

A mouse Cκ‐specific T cell clone indicates that DC‐SIGN is an efficient target for antibody‐mediated delivery of T cell epitopes for MHC class II presentation

Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes

Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target

Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates

Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level

Antibody‐mediated delivery of antigen to chemokine receptors on antigen‐presenting cells results in enhanced CD4+ T cell responses

Novel APC-like properties of human NK cells directly regulate T cell activation

Xeno-free serum replacement for ex vivo culture and expansion of T cells

Novel APC-like properties of human NK cells directly regulate T cell activation

Rapid isolation of pure, functional and bead-free T cells directly from whole blood using Dynabeads® FlowCompTM technology (42.11)

Retraction. Novel APC-like properties of human NK cells directly regulate T cell activation

Recombinant antibodies for delivery of antigen: a single loop between -strands in the constant region can accommodate long, complex and tandem T cell epitopes

Abstract A003: High-throughput TCR sequencing demonstrates induction of long-lasting HPV16-specific T cell responses in VB10.16 vaccinated advanced cervical cancer patients

Abstract CT274: Individualized APC targeting VB10.NEO cancer vaccines induce broad neoepitope-specific CD8 T cell responses in patients with advanced or metastatic solid tumors: interim results from a phase 1/2a trial

Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen‐specific CD4+8+ thymocytes

Suchergebnisse filtern